Omega Therapeutics, Inc.
NASDAQ:OMGA
0.7675 (USD) • At close January 8, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 68.443 | 70.615 | 186.482 | 22.951 | 2.274 |
| Short Term Investments
| 4.986 | 54.063 | 38.845 | 0 | 0 |
| Cash and Short Term Investments
| 73.429 | 70.615 | 225.327 | 22.951 | 2.274 |
| Net Receivables
| 6.986 | 1.798 | 0.521 | 0.193 | 0.005 |
| Inventory
| 0.303 | 41.151 | -0.264 | 0 | 0 |
| Other Current Assets
| 9.166 | 11.114 | 3.438 | 0.859 | 0.375 |
| Total Current Assets
| 89.884 | 124.678 | 229.286 | 24.003 | 2.654 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 114.047 | 7.863 | 3.605 | 3.482 | 2.833 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.341 | 0.341 | 0.341 | 0.341 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.435 | 13.116 | 0.101 | 0.257 | 0.292 |
| Total Non-Current Assets
| 114.482 | 21.32 | 4.047 | 4.08 | 3.466 |
| Total Assets
| 204.366 | 145.998 | 233.333 | 28.083 | 6.12 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 1.62 | 3.107 | 2.109 | 1.063 | 0.917 |
| Short Term Debt
| 15.3 | 6.381 | 0 | 3 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 3.277 | 0 |
| Other Current Liabilities
| 9.886 | 12.476 | 9.874 | 3.636 | 1.31 |
| Total Current Liabilities
| 26.806 | 21.964 | 11.983 | 7.699 | 2.227 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 113.128 | 17.723 | 19.869 | 8.732 | 11.892 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 6.416 | 0.34 | 0.853 | 76.28 | 27.92 |
| Total Non-Current Liabilities
| 119.544 | 18.063 | 20.722 | 85.012 | 39.812 |
| Total Liabilities
| 146.35 | 40.027 | 32.705 | 92.711 | 42.039 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 233.333 | 75.225 | 26.708 |
| Common Stock
| 0.055 | 0.048 | 0.048 | 0.005 | 0.005 |
| Retained Earnings
| -334.634 | -237.206 | -134.505 | -66.225 | -36.778 |
| Accumulated Other Comprehensive Income/Loss
| -0.014 | -0.479 | -0.062 | -75.225 | -26.708 |
| Other Total Stockholders Equity
| 392.609 | 343.608 | 335.147 | 150.45 | 53.427 |
| Total Shareholders Equity
| 58.016 | 105.971 | 200.628 | -64.628 | -35.919 |
| Total Equity
| 58.016 | 105.971 | 200.628 | -64.628 | -35.919 |
| Total Liabilities & Shareholders Equity
| 204.366 | 145.998 | 233.333 | 28.083 | 6.12 |